Multicentric Cohort of HIV Positive Patients FRESH-PEF60080-en Laurence MEYER Multicentric Cohort of HIV Positive Patients ANRS CO2 SEROCO/HEMOCO FRESH-PEF60080-en 60080 FRESH-PEF60080 Laurence MEYER AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE) Epidemiology France Portal (PEF) AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE) null Laurence;MEYER AIDS stage morbidity mortality health events Infectious disease medicine Behavioral determinants Environmental determinants: Other Socio-demographic and economic determinants Healthcare system determinants: Use of care Environmental determinants Healthcare system determinants General objective: to investigate spontaneous HIV disease progression and the treatment response of haemophiliac (HEMOCO) or non-haemophiliac (SEROCO) subjects. The prognostic role of markers, in particular CD4, HIV-RNA and HIV-DNA. null France Ile-de-France Provence - Alpes - Côte d\'Azur Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) SEROCCO: Seropositive HIV-1 patients (ELISA test confirmed by Western blot) with known date of contamination or whose HIV status is less than a year old (period between first positive sample date and the date the patient is enrolled in survey) and who do not have AIDS at baseline; attending physicians from centres participating in the survey; who are 18 years old or over and have given their informed consent. HEMOCO: HIV-seropositive haemophiliacs (ELISA test confirmed by Western blot); attending physicians from centres participating in the survey, who are 3 years old and over and have given their informed consent. Consent is signed by the parties with parental authority of dependent minors or by the legal guardians of minors under tutelage. Clinical data Participant-reported health data Biological data Consistency request after electronic data is recorded. Missing data is managed by returning to source record. Physician reminder for follow-up visits. Patients are informed about the use of their data. Health event/morbidity Health event/mortality Health care consumption and services Other Through organizations (health services or institutions schools businesses etc.) [1000-10000[ individuals Self-administered questionnaire Interview with the participant (including clinical) Observational Study Observational Study Cohort study - 1551 (SEROCO) - 197 (HEMOCO) Unknown Restricted access Data may be used by academic teams. Data may not be used by industrial teams. Access on specific project only